MG Motor India will soon launch a couple of new cars in the Indian market, and here we talk about them all. The list includes ...
Priced in the U.K. at 54,995 pounds (roughly $71,300) in base (Trophy) guise, the Cyberster squares off directly against the ...
16h
Zacks Investment Research on MSNIMVT Unlikely to Pursue Batoclimab for MG & CIDP Despite SuccessImmunovant IMVT announced top-line data from a late-stage study of its investigational candidate, batoclimab, for myasthenia ...
Running gels provide a quick energy boost, helping to maximize your performance. A running coach shares her picks of the best ...
Chugai introduces Lunsumio for intravenous infusion, a bispecific antibody to treat relapsed or refractory follicular lymphoma in Japan: Tokyo Thursday, March 20, 2025, 11:00 Hrs ...
18h
India Today on MSNBengaluru man goes on lengthy rant about why living in the city has become irritableIn the Reddit post titled "Why living in Bengaluru has become irritable recently," the user ‘Normal_Excuse_6303’ cited ...
During a live event, Catherine J. Lee, MD, MS, discussed the efficacy and safety results of various trials of approved agents ...
The popular anti-obesity drug Mounjaro has finally been launched in India. The development comes after Eli Lilly received ...
6d
MedPage Today on MSNApproved Sickle Cell Drug Fails to Beat Placebo in TrialCrizanlizumab (Adakveo) failed to outperform placebo in patients with sickle cell disease, the phase III STAND trial showed.
The FDA granted orphan drug designation to HLX22 for gastric cancer, advancing global phase 3 trials to improve first-line ...
Remission persisted through 104 weeks for most patients with eosinophilic granulomatosis with polyangiitis who used benralizumab, according to a poster presented here. Lower blood eosinophil counts ...
MacroGenics (NASDAQ: MGNX) Q4 2024 Earnings Call Mar 20, 2025, 4:30 p.m. ET ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results